Cite
Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms.
MLA
Wenning, L. A., et al. “Pharmacokinetics of Raltegravir in Individuals with UGT1A1 Polymorphisms.” Clinical Pharmacology and Therapeutics, vol. 85, no. 6, June 2009, pp. 623–27. EBSCOhost, https://doi.org/10.1038/clpt.2009.12.
APA
Wenning, L. A., Petry, A. S., Kost, J. T., Jin, B., Breidinger, S. A., DeLepeleire, I., Carlini, E. J., Young, S., Rushmore, T., Wagner, F., Lunde, N. M., Bieberdorf, F., Greenberg, H., Stone, J. A., Wagner, J. A., & Iwamoto, M. (2009). Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms. Clinical Pharmacology and Therapeutics, 85(6), 623–627. https://doi.org/10.1038/clpt.2009.12
Chicago
Wenning, L A, A S Petry, J T Kost, B Jin, S A Breidinger, I DeLepeleire, E J Carlini, et al. 2009. “Pharmacokinetics of Raltegravir in Individuals with UGT1A1 Polymorphisms.” Clinical Pharmacology and Therapeutics 85 (6): 623–27. doi:10.1038/clpt.2009.12.